metaraminol has been researched along with Substance-Related Disorders in 2 studies
Metaraminol: A sympathomimetic agent that acts predominantly at alpha-1 adrenergic receptors. It has been used primarily as a vasoconstrictor in the treatment of HYPOTENSION.
metaraminol : A member of the class of phenylethanolamines that is 2-amino-1-phenylethanol substituted by a methyl group at position 2 and a phenolic hydroxy group at position 1. A sympathomimetic agent , it is used in the treatment of hypotension.
Substance-Related Disorders: Disorders related to substance use or abuse.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Slotkin, TA | 1 |
| Anderson, TR | 1 |
| Milazzotto, F | 1 |
| Iacovella, G | 1 |
| Masini, V | 1 |
2 other studies available for metaraminol and Substance-Related Disorders
| Article | Year |
|---|---|
Sympatho-adrenal development in perinatally addicted rats.
Topics: Adrenal Medulla; Animals; Animals, Newborn; Catecholamines; Dopamine beta-Hydroxylase; Enzyme Induct | 1975 |
[Catecholamine dependence. Pathogenesis and treatment].
Topics: Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Catecholamines; Humans; Metaraminol; Methylphe | 1970 |